Get started
Neuraxis, Inc.Neuraxis, Inc.Neuraxis, Inc.

Neuraxis, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

NRXS chart


Full chart

NRXS upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪11.55 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.23 USD
Net income (FY)
‪−8.24 M‬ USD
Revenue (FY)
‪2.69 M‬ USD
Shares float
‪3.56 M‬
Beta (1Y)
0.39

Employees


Employees (FY)
21
Change (1Y)
+2 +10.53%
Revenue / Employee (1Y)
‪127.90 K‬ USD
Net income / Employee (1Y)
‪−392.45 K‬ USD

About Neuraxis, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Brian Carrico
Website
neuraxis.com
Headquarters
Carmel
Founded
2011
FIGI
BBG01C9N12C3
NeurAxis, Inc. engages in the provision of neuromodulation therapies to address chronic and debilitating conditions in children. Its product, IB-Stim, is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear. The company was founded by Gary Peterson and Christopher Robin Brown in 2011 and is headquartered in Carmel, IN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NRXS news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as NRXS.

Frequently Asked Questions


The current price of NRXS is 1.60 USD — it has decreased by −1.23% in the past 24 hours. Watch Neuraxis, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Neuraxis, Inc. stocks are traded under the ticker NRXS.
NRXS stock has risen by 0.63% compared to the previous week, the month change is a −30.43% fall, over the last year Neuraxis, Inc. has showed a −48.93% decrease.
We've gathered analysts' opinions on Neuraxis, Inc. future price: according to them, NRXS price has a max estimate of 4.75 USD and a min estimate of 4.75 USD. Watch NRXS chart and read a more detailed Neuraxis, Inc. stock forecast: see what analysts think of Neuraxis, Inc. and suggest that you do with its stocks.
NRXS reached its all-time high on Aug 9, 2023 with the price of 6.93 USD, and its all-time low was 1.33 USD and was reached on Apr 16, 2025. View more price dynamics on NRXS chart.
See other stocks reaching their highest and lowest prices.
NRXS stock is 10.32% volatile and has beta coefficient of 0.39. Track Neuraxis, Inc. stock price on the chart and check out the list of the most volatile stocks — is Neuraxis, Inc. there?
Yes, you can track Neuraxis, Inc. financials in yearly and quarterly reports right on TradingView.
Neuraxis, Inc. is going to release the next earnings report on May 21, 2025. Keep track of upcoming events with our Earnings Calendar.
NRXS earnings for the last quarter are −0.23 USD per share, whereas the estimation was 0.04 USD resulting in a −675.00% surprise. The estimated earnings for the next quarter are −0.24 USD per share. See more details about Neuraxis, Inc. earnings.
Neuraxis, Inc. revenue for the last quarter amounts to ‪761.16 K‬ USD, despite the estimated figure of ‪3.62 M‬ USD. In the next quarter, revenue is expected to reach ‪725.00 K‬ USD.
NRXS net income for the last quarter is ‪−1.45 M‬ USD, while the quarter before that showed ‪−1.76 M‬ USD of net income which accounts for 17.51% change. Track more Neuraxis, Inc. financial stats to get the full picture.
No, NRXS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 20, 2025, the company has 21 employees. See our rating of the largest employees — is Neuraxis, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Neuraxis, Inc. EBITDA is ‪−7.12 M‬ USD, and current EBITDA margin is −265.05%. See more stats in Neuraxis, Inc. financial statements.
Like other stocks, NRXS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Neuraxis, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Neuraxis, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Neuraxis, Inc. stock shows the sell signal. See more of Neuraxis, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.